KYNTRA BIO, INC. Stock Issued During Period, Shares, New Issues
KYNTRA BIO, INC. (KYNB) reported Stock Issued During Period, Shares, New Issues of 9.31 million shares for the 0-month period ending 2014-11-19, per its 10-K filed 2017-03-01.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2017-03-01
- 2014-11-19: Stock Issued During Period, Shares, New Issues 0 month 9.31M shares; Stock Issued During Period, Shares, New Issues 9.31M shares.
| Period end | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues |
|---|---|---|
| 2014-11-19 | 9.31M shares 10-K · filed 2017-03-01 | 9.31M shares 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |